Global Peripheral Arterial Disease (PAD) Drugs Market Study 2015-2025, by Segment (Clopidogrel (Plavix), Prasugrel (Effient), Ticagrelor (Brilinta)), by Market (Hospitals, ClinicsOthers, Others), by Company (AstraZeneca Plc. (UK), Bayer HealthCare Pharmaceuticals (Germany), Bristol-Myers Squibb Company (US))

October 2018 | 71 pages | ID: G67A074A22EEN
99Strategy

Abstracts

Snapshot

The global Peripheral Arterial Disease (PAD) Drugs market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Clopidogrel (Plavix)
• Prasugrel (Effient)
• Ticagrelor (Brilinta)
• Vorapaxar (Zontivity)
• Others

Demand Coverage (Market Size & Forecast, Consumer Distribution):

• Hospitals
• Clinics
• Others

Company Coverage (Sales data, Main Products & Services etc.):

• AstraZeneca Plc. (UK)
• Bayer HealthCare Pharmaceuticals (Germany)
• Bristol-Myers Squibb Company (US)
• Merck & Co., Inc. (US)
• Proteon Therapeutics, Inc. (US)
• Sanofi S.A. (France)
• Symic Bio, Inc. (US)
• TheraVasc Inc. (US)

Major Region Market

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Contents

1 INDUSTRY OVERVIEW

1.1 Peripheral Arterial Disease (PAD) Drugs Industry
  1.1.1 Overview
  1.1.2 Products of Major Companies
1.2 Market Segment
  1.2.1 Industry Chain
  1.2.2 Consumer Distribution
1.3 Price & Cost Overview

2 PERIPHERAL ARTERIAL DISEASE (PAD) DRUGS MARKET BY TYPE

2.1 By Type
  2.1.1 Clopidogrel (Plavix)
  2.1.2 Prasugrel (Effient)
  2.1.3 Ticagrelor (Brilinta)
  2.1.4 Vorapaxar (Zontivity)
  2.1.5 Others
2.2 Market Size by Type
2.3 Market Forecast by Type

3 GLOBAL MARKET DEMAND

3.1 Segment Overview
  3.1.1 Hospitals
  3.1.2 Clinics
  3.1.3 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand

4 MAJOR REGION MARKET

4.1 Global Market Overview
  4.1.1 Market Size & Growth
  4.1.2 Market Forecast
4.2 Major Region
  4.2.1 Market Size & Growth
  4.2.2 Market Forecast

5 MAJOR COMPANIES LIST

5.1 AstraZeneca Plc. (UK) (Company Profile, Sales Data etc.)
5.2 Bayer HealthCare Pharmaceuticals (Germany) (Company Profile, Sales Data etc.)
5.3 Bristol-Myers Squibb Company (US) (Company Profile, Sales Data etc.)
5.4 Merck & Co., Inc. (US) (Company Profile, Sales Data etc.)
5.5 Proteon Therapeutics, Inc. (US) (Company Profile, Sales Data etc.)
5.6 Sanofi S.A. (France) (Company Profile, Sales Data etc.)
5.7 Symic Bio, Inc. (US) (Company Profile, Sales Data etc.)
5.8 TheraVasc Inc. (US) (Company Profile, Sales Data etc.)

6 CONCLUSION

List Of Tables

LIST OF TABLES

TABLE GLOBAL PERIPHERAL ARTERIAL DISEASE (PAD) DRUGS MARKET 2015-2018, BY TYPE, IN USD MILLION

Table Global Peripheral Arterial Disease (PAD) Drugs Market 2015-2018, by Type, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Market Forecast 2019-2025, by Type, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market Forecast 2019-2025, by Type, in Volume
Table AstraZeneca Plc. (UK) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of AstraZeneca Plc. (UK) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer HealthCare Pharmaceuticals (Germany) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Bayer HealthCare Pharmaceuticals (Germany) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company (US) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Bristol-Myers Squibb Company (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co., Inc. (US) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Merck & Co., Inc. (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Proteon Therapeutics, Inc. (US) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Proteon Therapeutics, Inc. (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi S.A. (France) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Sanofi S.A. (France) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Symic Bio, Inc. (US) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Symic Bio, Inc. (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table TheraVasc Inc. (US) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of TheraVasc Inc. (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List Of Figures

LIST OF FIGURES

Figure Global Peripheral Arterial Disease (PAD) Drugs Market Growth 2015-2018, by Type, in USD Million
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Growth 2015-2018, by Type, in Volume